# A — Agilent Technologies · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** A  
**Sources:** 20  
**Published:** 2026-10-06  
**Canonical:** https://app.k3vl4r.com/research/deep-research-a-agilent-technologies-catalysts-narrative-risks-3472

---

## Agilent Technologies (NYSE: A) — point-in-time snapshot (as of Oct 6, 2026)

The stock closed at **$171.29 on Oct 5, 2026** [[6]](https://finance.yahoo.com/quote/A/news/), roughly a month after its last earnings report, during which shares rose about **9.6%**, outpacing the S&P 500 [[1]](https://www.msn.com/en-us/money/economy/agilent-a-up-9-6-since-last-earnings-report-can-it-continue/ar-AA2cYjTN). Market capitalization is ~$48.3B (internal record); sector/industry is Healthcare/Diagnostics & Research (internal). The 52-week high referenced in August was $160.51 [[2]](https://www.ad-hoc-news.de/boerse/news/corporate-news/agilent-technologies-stock-softens-ahead-of-q3-2026-earnings-as-investors/70001042), and Agilent now trades above that level. As the sources themselves note, conventional fundamental analysis still weighs metrics like P/E, dividend yield and ROE [LIB-2], and news/announcements remain a key predictive driver [LIB-3].

## Recent catalysts (last ~1–3 months)

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-a-agilent-technologies-catalysts-narrative-risks-3472 (free to sign up)._